Clinical use of PET/CT in thyroid cancer diagnosis and management

The incidence of thyroid cancer is low, but when it occurs, it is mainly of the papillary histopathological type. Although PET/CT has a limited role in the diagnosis, it plays a significant role in the overall post-surgery management of a patient with thyroid cancer. This follow-up role is important...

Descripción completa

Detalles Bibliográficos
Autor principal: Sundram, FX
Formato: Texto
Lenguaje:English
Publicado: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2006
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097816/
https://www.ncbi.nlm.nih.gov/pubmed/21614336
http://dx.doi.org/10.2349/biij.2.4.e56
_version_ 1782203898686078976
author Sundram, FX
author_facet Sundram, FX
author_sort Sundram, FX
collection PubMed
description The incidence of thyroid cancer is low, but when it occurs, it is mainly of the papillary histopathological type. Although PET/CT has a limited role in the diagnosis, it plays a significant role in the overall post-surgery management of a patient with thyroid cancer. This follow-up role is important, especially in patients with elevated serum thyroglobulin, but negative radioiodine whole body scans. There is increasing evidence that PET/CT should be a part of routine care in the Tg positive Radioiodine scan negative patient.
format Text
id pubmed-3097816
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
record_format MEDLINE/PubMed
spelling pubmed-30978162011-05-24 Clinical use of PET/CT in thyroid cancer diagnosis and management Sundram, FX Biomed Imaging Interv J Review Article The incidence of thyroid cancer is low, but when it occurs, it is mainly of the papillary histopathological type. Although PET/CT has a limited role in the diagnosis, it plays a significant role in the overall post-surgery management of a patient with thyroid cancer. This follow-up role is important, especially in patients with elevated serum thyroglobulin, but negative radioiodine whole body scans. There is increasing evidence that PET/CT should be a part of routine care in the Tg positive Radioiodine scan negative patient. Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2006-10-01 /pmc/articles/PMC3097816/ /pubmed/21614336 http://dx.doi.org/10.2349/biij.2.4.e56 Text en © 2006 Biomedical Imaging and Intervention Journal http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sundram, FX
Clinical use of PET/CT in thyroid cancer diagnosis and management
title Clinical use of PET/CT in thyroid cancer diagnosis and management
title_full Clinical use of PET/CT in thyroid cancer diagnosis and management
title_fullStr Clinical use of PET/CT in thyroid cancer diagnosis and management
title_full_unstemmed Clinical use of PET/CT in thyroid cancer diagnosis and management
title_short Clinical use of PET/CT in thyroid cancer diagnosis and management
title_sort clinical use of pet/ct in thyroid cancer diagnosis and management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097816/
https://www.ncbi.nlm.nih.gov/pubmed/21614336
http://dx.doi.org/10.2349/biij.2.4.e56
work_keys_str_mv AT sundramfx clinicaluseofpetctinthyroidcancerdiagnosisandmanagement

Ejemplares similares